关于胃癌治疗方法的系统审查的方法质量:一个横截面研究
Digestive surgery
|December 5, 2025
概括
大多数关于胃癌干预措施的系统性审查 (SRs) 的方法质量非常低. 改善协议建立和报告标准对于胃癌研究的可靠证据至关重要.
科学领域:
- 胃肠病学和肝病学
- 在瘤学瘤学.
- 基于证据的医学 基于证据的医学
背景情况:
- 系统性审查 (SRs) 对胃癌干预证据至关重要.
- 方法上的缺陷可能会损害SRs的可靠性.
- 评估SR质量对于提高研究严谨性至关重要.
研究的目的:
- 评估胃癌干预措施的SR的方法质量.
- 确定影响这些SR质量的因素.
主要方法:
- 搜索了四个主要的数据库 (MEDLINE,PsycInfo,Embase,Cochrane) 查找2014年1月至2023年10月发表的SR.
- 使用系统审查工具评估2 (AMSTAR 2) 仪器评估方法质量.
- 采用多变量回归来确定影响质量的因素.
主要成果:
- 在119个SR中,只有2.5%的SR质量高,89.1%的SR质量极低.
- 更高的期刊影响因子,更多的作者和最近的出版日期与更好的质量相关.
- 具体因素,如协议建立,利益冲突报告和异质性评估的影响力各不相同.
结论:
- 胃癌干预SRs的方法质量在很大程度上是不满意的.
- 未来的SR需要加强对协议,搜索策略和详细报告的关注.
- 改善SR质量对于推进胃癌治疗证据至关重要.
相关概念视频
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


